The Fetus and Newborn Conference

Sep 28, 2016 ‐ Oct 1, 2016


Total CE Credits:

56.75 - Physician

56.75 - RN/NP (All RNs/Nurses except CA RNs)

56.75 - CA RN/CA BRN

36.50 - Pharmacists

11.25 - Pharmacology

The Fetus & Newborn conference brings together clinical and research experts. Perinatal/neonatal medicine is truly a combination of art and science as the different sessions work towards best possible outcomes for patients and families. Learn at your own pace from experts in the fields of neonatal and perinatal medicine, nursing and pharmacology.

Senior Program Manager: Jeannine Strunk, BSN, RN

Disclosures: The Program Manager has nothing to disclose.

Standard: $679.00

Sessions

PK Knowledge to Improve Drug Dosing in the NICU (Rx = .75 hr.) ACPE #0263-000-16-645-L01-P (.75 contact hr.)

Sep 28, 2016 8:00am ‐ Sep 28, 2016 8:45am
Expiration Date: Oct 27, 2019

Identification: PC800

Credits: None available.

Learning Objectives:

  • The basic concepts of pharmacokinetics and pharmacodynamics.
  • Describe the clinical implications of how drug disposition changes in the newborn period with maturation.
  • Apply basic PK principles to improve drug dosing to achieve targeted serum concentrations for desired effect.

Speaker(s): Disclosures
  • Kelly Wade, MD, PhD, MSCE:

    This speaker has nothing to disclose

Standard: $15.00

Update of Dosing of Antifungals in the Nursery (Rx = .75 hr.) ACPE #0263-000-16-646-L01-P (.75 contact hr.)

Sep 28, 2016 8:45am ‐ Sep 28, 2016 9:30am
Expiration Date: Oct 27, 2019

Identification: PC845

Credits: None available.

Learning Objectives:

  • Describe recent pharmacokinetic findings in infants for antifungals.
  • Describe recent safety findings in infants for antifungals.
  • Describe recent dosing recommendation for treatment of Candida meningoencephalitis.

Speaker Disclosure:

Shionogi
Cempra
Abbvie

Speaker Relationship:

Contract
Contract
Consultant

Speaker(s): Disclosures
  • Brian Smith, MD, MPH, MHS:

    Disclosure:

    Shionogi
    Cempra
    Abbvie

    Relationship:

    Contract

    Contract
    Consultant

Standard: $15.00

Neonatal Hypoglycemia: American Academy of Pediatrics and Pediatric Endocrine Society Recommendations (Rx = .75 hr.) ACPE #0263-000-16-647-L01-P (.75 contact hr.)

Sep 28, 2016 10:00am ‐ Sep 28, 2016 10:45am
Expiration Date: Oct 27, 2019

Identification: PC1000

Credits: None available.

Learning Objectives:

  • Review Postnatal Glucose Homeostasis and Transitional Neonatal Hyperinsulinemia.
  • Discuss approaches to define Hypoglycemia in the Neonate.
  • Learn strategies to screen and manage low glucose levels as well as address ways to identify Persistent Hypoglycemic Syndromes.

Speaker(s): Disclosures
  • Avroy Fanaroff, MD:

    This speaker has nothing to disclose

Standard: $15.00

Strategies to Reduce Medication Errors in the NICU (Rx = .75 hr.) - Q&D (Rx = .5 hr.) - Faculty Panel - ACPE #0263-000-16-648-L05-P (1.25 contact hrs.)

Sep 28, 2016 10:45am ‐ Sep 28, 2016 12:00pm
Expiration Date: Oct 27, 2019

Identification: PC1045

Credits: None available.

Learning Objectives:

  • Recognize at least 2 potential medication errors in the NICU.
  • Describe at least one practice to reduce medication errors in the NICU.
  • Describe how inattentional blindness can contribute to medication errors.

Speaker(s): Disclosures
  • Kelly Wade, MD, PhD, MSCE:

    This speaker has nothing to disclose

Standard: $21.00

Choice of Empirical Antibiotic Therapy for Hospitalized Infants (Rx = .75 hr.) ACPE #0263-000-16-649-L01-P (.75 contact hr.)

Sep 28, 2016 1:30pm ‐ Sep 28, 2016 2:15pm
Expiration Date: Oct 27, 2019

Identification: PC130

Credits: None available.

Learning Objectives:

  • Describe recent pharmacokinetic findings in infants for antibiotics.
  • Describe recent safety findings in infants for antibiotics.
  • Describe factors influencing choice of empirical antibiotic therapy for hospitalized infants.


Speaker(s): Disclosures
  • Brian Smith, MD, MPH, MHS:

    Disclosure:

    Shionogi
    Cempra
    Abbvie

    Relationship:

    Contract

    Contract
    Consultant

Standard: $15.00

Vitamin D Health: What Do You Need to Know for NICU Care? (Rx = .75 hr.) ACPE #0263-000-16-650-L01-P (.75 contact hr.)

Sep 28, 2016 2:15pm ‐ Sep 28, 2016 3:00pm
Expiration Date: Oct 27, 2019

Identification: PC215

Credits: None available.

Learning Objectives:

  • Determine the current definition of vitamin D health.
  • Identify the evidence regarding vitamin D status and vitamin D intake for infants.
  • Determine methods to optimize vitamin D health of hospitalized infants.


Speaker(s): Disclosures
  • Sarah Taylor, MD:

    Disclosure:

    Medela
    Baxter Pharmaceuticals
    Sigma Tau

    Relationship:

    Research Advisory Council
    Local investigator for research study
    Local investigator for research study

Standard: $15.00

Pain and Sedation Management: Correlation to Neurologic Outcomes (Rx = .75 hr.) ACPE #0263-000-16-651-L01-P (.75 contact hr.)

Sep 28, 2016 3:15pm ‐ Sep 28, 2016 4:00pm
Expiration Date: Oct 27, 2019

Identification: PC315

Credits: None available.

Learning Objectives:

  • Describe the mechanism of action of commonly used sedatives.
  • Describe the concern regarding neurodevelopmental outcome and medication exposure.
  • Identify differences in drug metabolism unique to neonates.


Speaker(s): Disclosures
  • Denise Suttner, MD:

    Disclosure:

    Mallinckrodt

    Relationship:

    Speaker Bureau

Standard: $15.00

Best Practices in Human Milk Nutrition for Preterm Infants (Rx = .75 hr.) - Q&D (Rx = .5 hr.) - Faculty Panel - ACPE #0263-000-16-652-L01-P (1.25 contact hrs.)

Sep 28, 2016 4:00pm ‐ Sep 28, 2016 5:15pm
Expiration Date: Oct 27, 2019

Identification: PC400

Credits: None available.

Learning Objectives:

  • Determine the evidence-based practice of preterm infant feeding.
  • Identify the evidence regarding additives to human milk.
  • Determine the most efficacious and safest methods to feed preterm infants.


Speaker(s): Disclosures
  • Avroy Fanaroff, MD:

    Disclosure:

    Medela
    Baxter Pharmaceuticals
    Sigma Tau

    Relationship:

    Research Advisory Council
    Local investigator for research study
    Local investigator for research study

Standard: $21.00

Critical Considerations in Neonatology 2016 (Rx = .25 hr.) ACPE #0263-000-16-653-L01-P (.75 contact hr.)

Sep 29, 2016 8:00am ‐ Sep 29, 2016 8:45am
Expiration Date: Oct 27, 2019

Identification: THU800

Credits: None available.

Learning Objectives:

  • Know survival rates for VLBW infants.
  • Be aware of risks and benefits of antenatal corticosteroids for late preterm infants.
  • Know the importance of preventing hemorrhagic disease of the newborn.

Speaker(s): Disclosures
  • Avroy Fanaroff, MD:

    This speaker has nothing to disclose

Standard: $15.00

Nutritional Challenges in the VLBW Infant (Rx = .25 hr.) ACPE #0263-000-16-654-L01-P (.75 contact hr.)

Sep 29, 2016 8:45am ‐ Sep 29, 2016 9:30am
Expiration Date: Oct 27, 2019

Identification: THU845

Credits: None available.

Learning Objectives:

  • Review nutritional strategies with higher protein to energy ratios to prevent postnatal growth failure.
  • Evaluate the data on prevention of NEC with human milk, probiotics and lactoferrin.
  • Look at newer products and strategies to improve the fortification of human milk for VLBW infants.

Speaker(s):
  • Jae H. Kim, MD, PhD, Rady Children's Hospital San Diego
Disclosures
  • Jae Kim, MD, PhD:

    This speaker has nothing to disclose

Standard: $15.00
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content